Literature DB >> 18266301

CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.

Shinji Kagami1, Hidehisa Saeki, Yuichiro Tsunemi, Koichiro Nakamura, Yoshihiro Kuwano, Mayumi Komine, Takashi Nakayama, Osamu Yoshie, Kunihiko Tamaki.   

Abstract

CCL27 is one of the CC chemokines produced by epidermal keratinocytes and is suggested to be involved in the pathogenesis of inflammatory skin diseases. To clarify the contribution of CCL27 in skin inflammation, we created transgenic C57BL/6 mice that constitutively produce CCL27 in epidermal keratinocytes. These mice had high serum CCL27 levels and did not show any phenotypical change. Thus we stimulated these mice with various reagents by single and repeated application. Interestingly, only contact hypersensitivity to repeated application with fluorescein isothiocyanate was significantly enhanced in transgenic mice compared to non-transgenic mice. Under this condition, the numbers of inflammatory cells, CCR10-positive cells, CCR4-positive cells and cutaneous lymphocyte-associated antigen-positive cells were increased, and IL-4 mRNA expression was higher in the lesional skin of transgenic mice. Increased number of mast cells and higher serum IgE levels, which were similar to atopic dermatitis, were also observed. These results indicated that CCL27 modified inflammation by attracting CCR10-positive and CCR4-positive cells into the lesional skin, and may participate in the pathogenesis of Th2-shifted skin diseases such as atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266301     DOI: 10.1002/eji.200737685

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  CCR10 and its ligands in regulation of epithelial immunity and diseases.

Authors:  Na Xiong; Yaoyao Fu; Shaomin Hu; Mingcan Xia; Jie Yang
Journal:  Protein Cell       Date:  2012-06-08       Impact factor: 14.870

Review 2.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

3.  Convergent inactivation of the skin-specific C-C motif chemokine ligand 27 in mammalian evolution.

Authors:  Mónica Lopes-Marques; Luís Q Alves; Miguel M Fonseca; Giulia Secci-Petretto; André M Machado; Raquel Ruivo; L Filipe C Castro
Journal:  Immunogenetics       Date:  2019-05-02       Impact factor: 2.846

4.  Expression and regulation in the brain of the chemokine CCL27 gene locus.

Authors:  Chad Gunsolly; James D Nicholson; Samuel J Listwak; Dolena Ledee; Peggy Zelenka; Daniela Verthelyi; Svetlana Chapoval; Achsah Keegan; Leonardo H Tonelli
Journal:  J Neuroimmunol       Date:  2010-06-03       Impact factor: 3.478

5.  Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.

Authors:  Sara Trifari; Charles D Kaplan; Elise H Tran; Natasha K Crellin; Hergen Spits
Journal:  Nat Immunol       Date:  2009-07-05       Impact factor: 25.606

6.  Characterising the expression and function of CCL28 and its corresponding receptor, CCR10, in RA pathogenesis.

Authors:  Zhenlong Chen; Seung-Jae Kim; Abdul B Essani; Michael V Volin; Olga M Vila; William Swedler; Shiva Arami; Suncica Volkov; Latriese V Sardin; Nadera Sweiss; Shiva Shahrara
Journal:  Ann Rheum Dis       Date:  2014-05-15       Impact factor: 19.103

7.  RGS16 attenuates pulmonary Th2/Th17 inflammatory responses.

Authors:  Sucharita P Shankar; Mark S Wilson; Jeffrey A DiVietro; Margaret M Mentink-Kane; Zhihui Xie; Thomas A Wynn; Kirk M Druey
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

8.  The Skin-Brain Connection Hypothesis, Bringing Together CCL27-Mediated T-Cell Activation in the Skin and Neural Cell Damage in the Adult Brain.

Authors:  Nataliya L Blatt; Timur I Khaiboullin; Vincent C Lombardi; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Front Immunol       Date:  2017-01-16       Impact factor: 7.561

9.  Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer.

Authors:  Wenlong Zhong; Bo Wang; Hao Yu; Jianxun Lin; Kun Xia; Weibin Hou; Meihua Yang; Junyu Chen; Meng Yang; Xiaofei Wang; Jian Huang; Tianxin Lin
Journal:  Oncoimmunology       Date:  2020-06-27       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.